1. Home
  2. SNGX vs FGI Comparison

SNGX vs FGI Comparison

Compare SNGX & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

Logo FGI Industries Ltd.

FGI

FGI Industries Ltd.

HOLD

Current Price

$8.61

Market Cap

16.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
FGI
Founded
1987
1987
Country
United States
United States
Employees
N/A
426
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
16.0M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
SNGX
FGI
Price
$0.37
$8.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
205.9K
3.6M
Earning Date
05-08-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
0.17
Revenue
$119,371.00
N/A
Revenue This Year
N/A
$6.38
Revenue Next Year
N/A
$6.06
P/E Ratio
N/A
$45.47
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$3.14
52 Week High
$2.98
$19.93

Technical Indicators

Market Signals
Indicator
SNGX
FGI
Relative Strength Index (RSI) 44.18 59.56
Support Level $0.36 $5.25
Resistance Level $0.42 $10.46
Average True Range (ATR) 0.02 0.59
MACD -0.00 -0.08
Stochastic Oscillator 19.84 69.20

Price Performance

Historical Comparison
SNGX
FGI

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, it generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: